StaphVAX in Cardiovascular Surgery Patients

Clinical trial NCT00211913 · COMPLETED

Trial details

NCT number: NCT00211913
Sponsor: Nabi Biopharmaceuticals
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Staphylococcal Infections Cardiovascular Diseases Cardiovascular Surgical Procedures

Start date: 2004-06-01
Primary completion: 2005-10-01
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.